new. Since the 1980s, pharma and biotech have forged relationships, most of them driven....    The biotech sector's knack at innovation seems to come from the small size of most its companies, which ……

on the other side of the looking glass compared to 2009.    A year ago at this meeting and others, biotech... representatives -- those who still had jobs -- were predicting that 30% to 40% or more of biotech ……

    Early-stage green technology companies are taking a page from the biotech playbook: IPO... the biotech IPO boom of the 1990s, but this time it's firms in the clean tech industry filing S-1s ……

    The biotech's bottom line could benefit from sales of Tamiflu, one of the only treatments....    Since Fortune last checked in on it, the biotech has reported record first-quarter revenues, completed ……

for investors looking to delve into pharmaceutical and biotech stocks: Don't think you'll spot the next Amgen... biotech superstar. "When you've adopted that sort of mindset," he says, "you can pick them ……

    For the biotech, a new drug for bone cancer and osteoporosis could mean a big boost in revenue...).    The biotech expects an FDA decision on DMab as an osteoporosis therapy by Oct. 19. Yoo says ……

pulling away from small biotech firms, which were short on credit, and wooing large pharmaceutical ……

to differentiate much between the two," says Ren Benjamin, a senior biotech analyst from Rodman & Renshaw....    The frontrunner in the adult stem cell space is Osiris Therapeutics (OSIR). Last year, the biotech Genzyme ……

    Biotech firm Illumina will sequence your entire genetic code -- and throw in a Mac -- for $48... is biotech startup Knome. It charges $99,500.    Genome sequencing can alert individuals if they have ……

that Lilly needs.    Lilly just bought biotech Alnara in July in hopes of getting the smaller... with their backs against the wall and buy a promising big biotech or merge with Bristol Myers Squibb (BMY ……

.    "We can't yet take it seriously as a business," says biotech analyst Michael King, a managing... employs 60 people.    Soon after launching, the Avey-Wojcicki team became the first outsized biotech ……

at Merck's scorecard maybe four or five years ago and how we were looked upon in dealing with biotech... of smaller biotech companies. Is bigger necessarily better?    If you're bringing two large ……

is on the verge of gaining immense, new power to heal," he declared.    Biotech companies like Celera ……

, a Minnesota biotech company formed in 1984 that was dissolved in 2005.    The boom in Chinese companies ……

time deals also slipped to their lowest level since 2009.    While biotech and pharma deals... quarter went to biotech firm Reata Pharamceuticals. The company, which is developing anti ……